Jingyu Zhang1, Di Tian1, Ziqi Xiong1, Yifan He1, and Zhiyong Li1
1The First Affiliated Hospital of Dalian Medical University, Dalian, China
Synopsis
Keywords: Heart, Kidney
T2
mapping is used to assess the degree of myocardial damage in CKD patients, and
T2 values increase as the glomerular filtration rate decreases in CKD patients.
Introduction
Patients
with chronic kidney disease (CKD) have high-load left ventricle (LV) structural
abnormalities, which are characterized by LV hypertrophy, diffuse interstitial
fibrosis and capillary sparing.1 Cardiovascular
magnetic resonance (CMR) myocardial T2 mapping allows for quantitative tissue
characterization and non-invasive direct measurement of pathological myocardium. T2
mapping is water-specific, indicating excess myocardial fluid, such as edema,
injury, and/or inflammation.2 We aim to
evaluate the changes in myocardial edema during different processes in CKD
patients using the T2 mapping technique.Methods
We prospectively recruited 44 CKD patients
who estimated
glomerular filtration rate (eGFR) < 59 ml/min/1.73 m2. All participants
with CMR scans were performed on a 3.0T MRI scanner (Philips Ingenia, Philips
Healthcare, Cleveland, Ohio, USA) for the acquisition of myocardial T2 mapping.
T2
mapping (GradientRecalled And Spin Echo sequences) was performed at identical
mid short-axis levels. Typical T2 acquisition parameters: ECG triggered, flip
angle 90°, voxel
size s 2×2×10 mm,
slice thickness 10 mm. Motion correction and fitting were performed to estimate
coefficients of the decay function, which were then used to estimate T2 times. Commercially
available dedicated software CVI42 (version 5.14, Circle Cardiovascular Imaging
Inc., Calgary, Canada) was used to analyze the T2 value. We
classified CKD as stage 3, stage 4, and stage 5(PRIMO) according to eGFR 30-59
ml/min/1.73m2, 15-29 ml/min/1.73m2, and <15
ml/min/1.73m2. The
Shapiro-Wilk test assessed the normality of the data. Analysis of variance
using independent samples t-test and Mann-Whitney U test. Pearson correlation
and Spearman rank correlation were used for correlation analysis.Results
The T2
values for patients with CKD stages 3-5 were 49.55±4.34 ms;
50(49,56) ms; 54.92±4.33 ms
shown (Table1). T2 values significantly increase (r=-0.349) as progressive CKD severity.
A significant difference in T2 values between CKD stages 3 and 5.Discussion
T2 mapping
values are negatively correlated with eGFR levels in CKD patients, which also related
to myocardial edema.3 Myocardial
edema exacerbates pathophysiological changes in the heart, including left
ventricular hypertrophy (LVH), leading to systolic and diastolic dysfunction. 1 T2
mapping technique as a non-invasive method to assess the impact of disease
severity on the myocardium in patients with CKD and to provide guidance for
clinical management.Conclusion
Myocardial
T2 time increased with progressive CKD severity, which can help assess the
association between the CKD disease process and myocardial edema.Acknowledgements
No acknowledgement found.References
1.
Kaesler
N, Babler A, Floege J, Kramann R. Cardiac Remodeling in Chronic Kidney Disease.
Toxins (Basel). 2020 Mar 5;12(3):161
2.
Arcari
L, Engel J, Freiwald T, Zhou H, Zainal H, Gawor M, Buettner S, Geiger H, Hauser
I, Nagel E, Puntmann VO. Cardiac biomarkers in chronic kidney disease are
independently associated with myocardial edema and diffuse fibrosis by
cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2021 Jun
7;23(1):71.
3.
Hayer
MK, Radhakrishnan A, Price AM, Liu B, Baig S, Weston CJ, Biasiolli L, Ferro CJ,
Townend JN, Steeds RP, Edwards NC; Birmingham Cardio-Renal Group. Defining
Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac
Magnetic Resonance Imaging Study. JACC Cardiovasc Imaging. 2020
Nov;13(11):2357-2367.